Although anti-TG2 plasma cells are well-established in the gut of CeD patients [16,25,26,34,40,41], studies have found that serum TG2 antibodies and TG2 antibodies produced in the intestine have distinct molecular composition [34]. The gene discussed is TGM2; the disease is cranioectodermal dysplasia.